Santhera Pharmaceuticals Holding AG
SANN
Rank in Stocks
#16268
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company,... Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company’s lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.
Share Price
$18.73
Market Cap
$286.57M
Change (1 day)
-0.14%
Change (1 year)
42.91%
Country
CH
Trade Santhera Pharmaceuticals Holding AG (SANN)
Category
Healthcare
Market Capitalization of Santhera Pharmaceuticals Holding AG(SANN)
Market Cap: $286.57M
As of October 2026 Santhera Pharmaceuticals Holding AG has a market cap of $286.57M. This makes Santhera Pharmaceuticals Holding AG the world's 16268th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Santhera Pharmaceuticals Holding AG from 2014 to 2026
SANN compared with Top 5 Most Popular stocks
